Menü
sharewise sharewise
Einloggen
Registrieren
Einloggen
Registrieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Mizuho 

Leap Therapeutics Inc diskutieren

Leap Therapeutics Inc.

WKN: A3EMJP / Symbol: LPTX / Name: Leap Therapeutics / Aktie / Micro Cap /

2,94 €
-1,38 %

7 0
7
0
Einschätzung Buy
Rendite (%) -42,79 %
Kursziel 1,88
Veränderung
Endet am 17.03.24

Leap Therapeutics, Inc. (NASDAQ: LPTX) had its price target lowered by analysts at Mizuho from $3.00 to $2.00. They now have a "buy" rating on the stock.
Ratings data for LPTX provided by MarketBeat

Mizuho 
0
Melden Teilen
17.03.23
Einschätzung Buy
Rendite (%) -19,05 %
Kursziel 1,83
Veränderung
Endet am 17.04.24

Leap Therapeutics, Inc. (NASDAQ: LPTX) had its "buy" rating re-affirmed by analysts at Mizuho. They now have a $2.00 price target on the stock.
Ratings data for LPTX provided by MarketBeat

Mizuho 
0
Melden Teilen
17.04.23
Einschätzung Buy
Rendite (%) 512,50 %
Kursziel 6,41
Veränderung
Endet am 15.08.24

Leap Therapeutics, Inc. (NASDAQ: LPTX) had its price target raised by analysts at HC Wainwright to $7.00. They now have a "buy" rating on the stock.
Ratings data for LPTX provided by MarketBeat

HC Wainwright 
0
Melden Teilen
15.08.23
Einschätzung Buy
Rendite (%) 113,14 %
Kursziel 16,21
Veränderung
Endet am 14.11.24

Leap Therapeutics, Inc. (NASDAQ: LPTX) had its price target lowered by analysts at Raymond James from $18.50 to $17.50. They now have an "outperform" rating on the stock.
Ratings data for LPTX provided by MarketBeat

Raymond James 
0
Melden Teilen
14.11.23
Einschätzung Buy
Rendite (%) 56,38 %
Kursziel 10,97
Veränderung
Endet am 20.11.24

Leap Therapeutics, Inc. (NASDAQ: LPTX) had its price target lowered by analysts at Mizuho from $20.00 to $12.00. They now have a "buy" rating on the stock.
Ratings data for LPTX provided by MarketBeat

Mizuho 
0
Melden Teilen
20.11.23
Einschätzung Buy
Rendite (%) 44,55 %
Kursziel 6,45
Veränderung
Endet am 19.03.25

Leap Therapeutics, Inc. (NASDAQ: LPTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Ratings data for LPTX provided by MarketBeat

HC Wainwright 
0
Melden Teilen
19.03.24
Noch kein Mitglied? Jetzt kostenlos registrieren!

Neueste Beiträge

StockNews_com in Hudson Global Inc. diskutieren
Hudson Global, Inc. (NASDAQ: HSON) is now covered by ana...
05.05.24
StockNews_com in Lipocine Inc diskutieren
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts ...
05.05.24
StockNews_com in Recon Technology Ltd. diskutieren
Recon Technology, Ltd. (NASDAQ: RCON) is now covered by ...
05.05.24
StockNews_com in Discuss Stratasys Inc.
Stratasys Ltd. (NASDAQ: SSYS) is now covered by analysts...
05.05.24
StockNews_com in Tonix Pharma. Holding Corp. diskutieren, Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is no...
05.05.24
StockNews_com in Farmer Brothers Co. diskutieren
Farmer Bros. Co. (NASDAQ: FARM) was upgraded by analysts...
04.05.24
StockNews_com in Discuss Faro Technologies Inc.
FARO Technologies, Inc. (NASDAQ: FARO) was upgraded by a...
04.05.24
StockNews_com in Liquidity Services diskutieren
Liquidity Services, Inc. (NASDAQ: LQDT) was upgraded by ...
04.05.24
Mehr anzeigen